Phase 1 Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2018
At a glance
- Drugs TTC 352 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors TTC Oncology
- 04 Jan 2018 Status changed from not yet recruiting to recruiting.
- 11 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Dec 2017.
- 03 Jul 2017 New trial record